OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,497 | +113.7% | 70,859 | +251.2% | 0.00% | – |
| Q2 2023 | $104,098 | -59.0% | 20,174 | -58.2% | 0.00% | – |
| Q1 2023 | $254,177 | +460.8% | 48,231 | +199.0% | 0.00% | – |
| Q4 2022 | $45,322 | -100.0% | 16,129 | -79.0% | 0.00% | -100.0% |
| Q3 2022 | $318,691,000 | -25.4% | 76,793 | -27.7% | 0.00% | 0.0% |
| Q2 2022 | $427,073,000 | -39.2% | 106,237 | -25.2% | 0.00% | 0.0% |
| Q1 2022 | $702,756,000 | -43.8% | 141,971 | -20.9% | 0.00% | -50.0% |
| Q4 2021 | $1,251,401,000 | +822.9% | 179,541 | +1224.0% | 0.00% | – |
| Q3 2021 | $135,600,000 | +236.0% | 13,560 | +376.5% | 0.00% | – |
| Q2 2021 | $40,356,000 | -74.3% | 2,846 | -70.2% | 0.00% | – |
| Q1 2021 | $156,929,000 | -43.3% | 9,563 | -28.5% | 0.00% | -100.0% |
| Q4 2020 | $276,738,000 | +154.7% | 13,369 | -6.4% | 0.00% | – |
| Q3 2020 | $108,648,000 | +513.5% | 14,277 | +571.5% | 0.00% | – |
| Q2 2020 | $17,710,000 | -72.8% | 2,126 | -83.8% | 0.00% | – |
| Q1 2020 | $65,088,000 | +159.7% | 13,149 | +107.2% | 0.00% | – |
| Q4 2019 | $25,067,000 | +38.9% | 6,346 | +6.9% | 0.00% | – |
| Q3 2019 | $18,042,000 | +0.7% | 5,935 | +45.7% | 0.00% | – |
| Q2 2019 | $17,921,000 | -39.8% | 4,073 | -45.7% | 0.00% | – |
| Q1 2019 | $29,791,000 | +303.2% | 7,504 | +598.7% | 0.00% | – |
| Q3 2018 | $7,389,000 | +1.9% | 1,074 | 0.0% | 0.00% | – |
| Q2 2018 | $7,250,000 | -82.6% | 1,074 | -83.2% | 0.00% | – |
| Q1 2018 | $41,710,000 | +76.8% | 6,407 | +20.8% | 0.00% | – |
| Q4 2017 | $23,594,000 | +56.0% | 5,302 | +116.7% | 0.00% | – |
| Q3 2017 | $15,122,000 | -44.6% | 2,447 | -16.8% | 0.00% | – |
| Q2 2017 | $27,272,000 | +3526.6% | 2,942 | +3532.1% | 0.00% | – |
| Q1 2017 | $752,000 | -91.4% | 81 | -92.2% | 0.00% | – |
| Q4 2016 | $8,730,000 | +4.9% | 1,043 | -13.9% | 0.00% | – |
| Q3 2016 | $8,320,000 | +139.4% | 1,211 | +72.5% | 0.00% | – |
| Q2 2016 | $3,475,000 | -86.6% | 702 | -74.6% | 0.00% | – |
| Q4 2015 | $25,918,000 | -41.9% | 2,766 | -12.9% | 0.00% | – |
| Q3 2015 | $44,641,000 | +95.8% | 3,175 | +192.9% | 0.00% | – |
| Q2 2015 | $22,797,000 | +314.6% | 1,084 | +727.5% | 0.00% | – |
| Q1 2015 | $5,499,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $116,310,000 | 100.00% |
| Opaleye Management Inc. | 6,510,000 | $134,758,000 | 17.60% |
| DELTEC ASSET MANAGEMENT LLC | 2,168,573 | $44,889,000 | 6.87% |
| Versant Venture Management, LLC | 1,465,384 | $30,333,000 | 3.15% |
| GREAT POINT PARTNERS LLC | 856,162 | $17,723,000 | 2.88% |
| Affinity Asset Advisors, LLC | 220,000 | $4,554,000 | 2.41% |
| Altium Capital Management LP | 303,174 | $6,276,000 | 2.34% |
| Endurant Capital Management LP | 290,465 | $6,013,000 | 2.17% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 50,396 | $1,043,000 | 1.17% |
| Lisanti Capital Growth, LLC | 366,040 | $7,577,000 | 1.05% |